LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 59.85 | 27.76 | 2957 | 6062 | 0.4877 | 0.8235 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 59.85 | 27.76 | 474 | 6062 | 0.0782 | 0.4408 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 59.85 | 27.76 | 2952 | 6062 | 0.4869 | 0.8231 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 61.56 | 27.76 | 3076 | 6217 | 0.4948 | 0.8276 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 61.56 | 27.76 | 3089 | 6217 | 0.4969 | 0.8286 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 61.56 | 27.76 | 520 | 6217 | 0.0836 | 0.4555 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 61.56 | 27.76 | 3014 | 6217 | 0.4848 | 0.8229 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 63.26 | 27.76 | 3154 | 6465 | 0.4878 | 0.8255 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 63.26 | 27.76 | 3171 | 6465 | 0.4904 | 0.8268 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 63.26 | 27.76 | 539 | 6465 | 0.0834 | 0.4582 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 63.26 | 27.76 | 3166 | 6465 | 0.4897 | 0.8264 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 64.97 | 27.76 | 3282 | 6656 | 0.4930 | 0.8289 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 64.97 | 27.76 | 3299 | 6656 | 0.4956 | 0.8301 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 64.97 | 27.76 | 584 | 6656 | 0.0877 | 0.4701 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 64.97 | 27.76 | 3288 | 6656 | 0.4939 | 0.8293 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 66.67 | 27.76 | 3393 | 6695 | 0.5067 | 0.8354 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 66.67 | 27.76 | 3409 | 6695 | 0.5091 | 0.8365 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 66.67 | 27.76 | 632 | 6695 | 0.0944 | 0.4842 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 66.67 | 27.76 | 3313 | 6695 | 0.4948 | 0.8299 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 68.37 | 27.76 | 3483 | 6879 | 0.5063 | 0.8360 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 68.37 | 27.76 | 3503 | 6879 | 0.5092 | 0.8373 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 68.37 | 27.76 | 630 | 6879 | 0.0916 | 0.4808 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 68.37 | 27.76 | 3500 | 6879 | 0.5088 | 0.8371 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 70.08 | 27.76 | 3599 | 6849 | 0.5254 | 0.8444 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 70.08 | 27.76 | 3615 | 6849 | 0.5278 | 0.8455 | MN20160318_Q01 | I11 |